Legend Biotech ROA 2019-2021 | LEGN
For a detailed definition, formula and example for ROA, check out our new background page here.
Current and historical return on assets (ROA) values for Legend Biotech (LEGN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Legend Biotech ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2021-06-30 |
$-0.30B |
$0.88B |
-40.82% |
| 2021-03-31 |
$-0.34B |
$0.62B |
-48.40% |
| 2020-12-31 |
$-0.30B |
$0.72B |
-47.35% |
| 2020-09-30 |
$-0.31B |
$0.71B |
-58.08% |
| 2020-06-30 |
$-0.27B |
$0.77B |
-76.02% |
| 2020-03-31 |
$-0.17B |
$0.37B |
-101.07% |
| 2019-12-31 |
$-0.13B |
$0.29B |
-184.72% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$7.681B |
$0.076B |
|
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
|
